By Tarun Sai Lomte Struggling with long COVID symptoms? New research confirms that pulmonary rehabilitation can restore lung ...

Fred Hutch virologist Keith Jerome, MD, PhD, and evolutionary biologist Jesse Bloom, PhD, were recently elected to the 2025 ...

A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...

For household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at ...

People who later experienced persistent shortness of breath or fatigue after a SARS-CoV-2 infection were already taking ...

Between April 2020 and December 2022, over 535,000 people in Germany downloaded and activated the Corona Data Donation App ...

In two recent interviews on Fox News, HHS Secretary Robert F. Kennedy Jr. downplayed concerns about H5N1 avian influenza in the U.S., raising alarm among public health and infectious disease experts.

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

Long COVID symptoms persisted for up to two years in more than half of the individuals who experienced the condition, according to new research published in BMC Medicine.

Scientists have learned more about how SARS-CoV-2 infections, which cause COVID-19, can ruin the ability of immune cells to ...

SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.

That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...